Is Rice Bran Cholesterol Meta-Analysis safe?

The current Migaku evidence database contains 2 reusable source documents for Rice Bran Cholesterol Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - Rice bran significantly reduced systolic blood pressure (WMD: -3.336 mmHg; p = 0.0006), diastolic blood pressure (WMD: -3.145 mmHg; p = 0.015), and HbA1c (WMD: -0.199%; p = 0.003). [Tantayakhom S (2025); evidence level 1] - Lipid profiles improved, with reductions in total cholesterol (WMD: -13.594 mg/dL; p p p = 0.007). [Tantayakhom S (2025); evidence level 1] - Rice bran, a fiber-rich source of bioactive compounds, has gained attention for its potential health benefits, yet its effects on metabolic syndrome (MetS) remain unclear. [Tantayakhom S (2025); evidence level 1] - This study aimed to evaluate the impact of rice bran consumption on anthropometric measures, blood pressure, glycemic control, and lipid profiles in individuals with MetS. [Tantayakhom S (2025); evidence level 1] - And for the last several decades, researchers have continued to provide evidence for the benefits of higher fiber intake, especially for cereal fibers, on an array of health outcomes, with the greatest effects reported among low-fiber consumers and consumers of Western-style diets (–). [Comerford Kevin B. (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.